The University and GSK will work along with scientists from other organisations at Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation bioscience campus, located near with GSK’s R&D centre.
This bioscience park provides an independent scientific community allowing scientists to build relationships across organisations and share their expertise and knowledge. Therefore those based at the park share access to specialist skills, scientific equipment and expertise. This should stimulate innovation and speed up the discovery and development process.
Patrick Vallance, president of pharmaceuticals R&D at GlaxoSmithKline, said: “This open innovation approach is enabling scientists who might not ordinarily have interacted to build relationships, share ideas and seek advice…This environment provides us with an opportunity to stimulate research and translate science into the discovery of new medicines for patients.